In the wake of the increase in Current Liabilities in the second quarter 2016, Quick Ratio fell to 0.01 a new company low.

Within Major Pharmaceutical Preparations industry 308 other companies have achieved higher Quick Ratio than Rock Creek Pharmaceuticals in second quarter 2016. While Quick Ratio total ranking in the second quarter 2016 has deteriorated compared to the prior quarter from 4216 to 5123.

Explain Quick Ratio?
How much Cash & cash equivalents RCPI�s has?
What are RCPI�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

RCPI Quick Ratio	(Jun 30 2016) Q2	(Mar 31 2016) Q1	(Dec 31 2015) Q4	(Sep 30 2015) Q3	(Jun 30 2015) Q2
Y / Y Current Liabilities Change	109.58 %	51.11 %	14.39 %	2.82 %	2.25 %
Y / Y Cash & cash equivalent Change	-93.82 %	506.59 %	24.81 %	-94.53 %	-20.17 %
Quick Ratio MRQ	0.01	0.03	0.02	0.01	0.28
RCPI's Total Ranking	# 5123	# 4216	# 5139	# 4470	# 2809
Seq. Current Liabilities Change	0.87 %	-1.62 %	98.51 %	6.4 %	-27.28 %
Seq. Cash & cash equivalent Change	-66.49 %	11.97 %	237.67 %	-95.12 %	3189.01 %

Quick Ratio second quarter 2016 Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 309
Healthcare Sector	# 854
Overall Market	# 5123

Quick Ratio Statistics
High	Average	Low
1.98	0.3	0.01
(Dec 31 2011)		(Mar 31 2015)

Financial Statements
Rock Creek Pharmaceuticals's Current Liabilities	$ 22 Millions	Visit RCPI's Balance sheet
Rock Creek Pharmaceuticals's Cash & cash equivalent	$ 0 Millions	Visit RCPI's Balance sheet
Source of RCPI's Sales		Visit RCPI's Sales by Geography

Cumulative Rock Creek Pharmaceuticals's Quick Ratio

RCPI's Quick Ratio for the trailling 12 Months

RCPI Quick Ratio	(Jun 30 2016) 12 Months	(Mar 31 2016) 12 Months	(Dec 31 2015) 12 Months	(Sep 30 2015) 12 Months	(Jun 30 2015) 12 Months
Y / Y Current Liabilities TTM Growth	39.83 %	19.48 %	27.61 %	74.72 %	112.41 %
Y / Y Cash & cash equivalent TTM Growth	-77.61 %	-39.38 %	-78.1 %	-86.56 %	-84.82 %
Quick Ratio TTM	0.02	0.06	0.06	0.07	0.11
Total Ranking TTM	# 3732	# 3526	# 3725	# 3515	# 3554
Seq. Current Liabilities TTM Growth	17.52 %	12.66 %	5.03 %	0.56 %	0.42 %
Seq. Cash & cash equivalent TTM Growth	-67.11 %	12.38 %	2.7 %	-41.02 %	-10.95 %

Quick ratio ranking by company, industry and sector >> Back to RCPI Financial Strength Comparisons >> Go to Compare RCPI Quick Ratio to its Competitors

On the trailing twelve months basis Due to rise in Current Liabilities in the Q2 2016 to $22.02 millions, cumulative Quick Ratio decreased to 0.02 below the Rock Creek Pharmaceuticals, Inc. average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 197 other companies have achieved higher Quick Ratio than Rock Creek Pharmaceuticals. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2016 from 3526 to 3732.

Explain Quick Ratio?
How much Cash & cash equivalents RCPI�s has?
What are RCPI�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Major Pharmaceutical Preparations Industry	# 198
Healthcare Sector	# 475
Within the Market	# 3732

trailing twelve months Quick Ratio Statistics
High	Average	Low
0.37	0.16	0.02
(Dec 31 2014)		(Jun 30 2016)

Companies with similar Quick Ratio in the quarter ending Jun 30 2016, within Major Pharmaceutical Preparations Industry	Quick Ratio	Jun 30 2016 MRQ Cash & cash equivalent	Jun 30 2016 MRQ Current Liabilities
Gt Biopharma Inc	0.02	$ 0.355 Millions	$ 15.666 Millions
Sunwin Stevia International Inc.	0.02	$ 0.175 Millions	$ 8.634 Millions
Wellness Center Usa Inc	0.02	$ 0.018 Millions	$ 0.928 Millions
Nanomix Corp	0.02	$ 0.021 Millions	$ 1.232 Millions
Lftd Partners Inc	0.02	$ 0.001 Millions	$ 0.053 Millions
Bioadaptives Inc	0.02	$ 0.005 Millions	$ 0.297 Millions
Lunai Bioworks Inc	0.02	$ 0.023 Millions	$ 1.508 Millions
Globestar Therapeutics Corporation	0.01	$ 0.009 Millions	$ 0.663 Millions
9 Meters Biopharma Inc	0.01	$ 0.152 Millions	$ 12.167 Millions
Biostax Corp	0.01	$ 0.064 Millions	$ 7.006 Millions
Rock Creek Pharmaceuticals, Inc.	0.01	$ 0.185 Millions	$ 22.023 Millions
Processa Pharmaceuticals Inc	0.01	$ 0.015 Millions	$ 2.214 Millions
Axim Biotechnologies Inc	0.01	$ 0.019 Millions	$ 2.988 Millions
Entest Group Inc	0.01	$ 0.005 Millions	$ 0.849 Millions
Nuvalent Inc	0.01	$ 0.013 Millions	$ 2.486 Millions
United Cannabis Corp	0.00	$ 0.009 Millions	$ 2.083 Millions
Shattuck Labs Inc	0.00	$ 0.014 Millions	$ 4.529 Millions
Dar Bioscience Inc	0.00	$ 0.037 Millions	$ 14.462 Millions
Cen Biotech Inc	0.00	$ 0.019 Millions	$ 10.781 Millions

Date modified: 2026-09-08T15:08:27+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.